News
Citing workplace violence, one-fourth of critical care workers are ready to quit
A new study finds that 25% of health care workers polled were willing to quit because of violence while at work.
News
Review cautions against influencer-promoted hair-growth remedies
Dermatologists reviewed five treatments that represent some of the most frequently discussed hair-growth trends on social media: rosemary, onion...
News
Dermatologists skeptical of calamine lotion TikTok trend
Although these ingredients are exceedingly safe with temporary, localized use, high concentrations and chronic use of calamine lotion can be...
News
FDA authorizes intradermal use of Jynneos vaccine for monkeypox
Intradermal administration will allow providers to get five doses out of a one-dose vial.
News
James Roberts, MD, trailblazer in EM, dies at age 76
Dr. Roberts was among the first physicians in the world to be board certified in EM and coauthored the foundational EM text.
News
Topical roflumilast approved for psoriasis in adults and adolescents
In clinical trials, topical roflumilast was effective in treating psoriasis in intertriginous areas, including the buttocks, underarms, and...
News
FDA approves belimumab for children with lupus nephritis
Children with lupus-related kidney damage can now receive the B cell–reducing therapy that adults with lupus nephritis have been able to get for...
News
Genetic link adds to gut-brain axis theory in Alzheimer’s disease
The same genes that influence Alzheimer’s disease were found in a host of gut disorders, according to a new study out of Australia.
News
FDA approves topical ruxolitinib for nonsegmental vitiligo
Approval was based on the results of two phase 3 trials in 674 patients with nonsegmental vitiligo aged 12 years or older.
News
FDA approves combination pegloticase and methotrexate for refractory gout
In the phase 4 trial, co-administration of pegloticase and methotrexate reduced the formation of new anti-PEG antibodies.
News
CDC recommends high-dose flu vaccines for seniors
These types of vaccines work by creating a larger immune response than a standard vaccine dose.
News
Heart attack care not equal for women and people of color
Over time, even with improvements across the board in care, women and people of color wait longer for treatment of myocardial infarction than...
News
Irritable bowel syndrome therapy removed from market (again)
Zelnorm, a short-term IBS-C treatment, has been removed from the market. The drug manufacturer cited “business concerns.”
News
FDA Class I recall: Batteries for CARESCAPE 2860 Ventilator
When using the backup power source, clinicians should make sure to have alternative routes for breathing support on hand.